Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Merck
Boehringer Ingelheim
Baxter
Dow

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Glaxo Group Ltd. v. Lupin Ltd. (D. Del. 2008)

See Plans and Pricing

« Back to Dashboard

Glaxo Group Ltd. v. Lupin Ltd. (D. Del. 2008)

Docket   Start Trial Date Filed 2008-08-29
Court District Court, D. Delaware Date Terminated 2011-11-04
Cause 35:271 Patent Infringement Assigned To Judge Jerome B. Simandle
Jury Demand None Referred To Judge Ann Marie Donio
Parties GLAXO GROUP LTD.; LUPIN LTD.; LUPIN PHARMACEUTICALS INC.; SMITHKLINE BEECHAM CORPORATION
Patents 5,859,021; 5,905,082
Attorneys John C. Phillips , Jr.; Karen Jacobs; Karen Jacobs Louden
Link to Docket External link to docket
Small Molecule Drugs cited in Glaxo Group Ltd. v. Lupin Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Glaxo Group Ltd. v. Lupin Ltd. (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-08-29 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,859,021; (dzs, ) (Entered: … OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 5,859,021 …Lupin Ltd. et al PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2011-11-07 45 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,859,021. (Attachments: # 1 …2008 4 November 2011 1:08-cv-00551 830 Patent None District Court, D. Delaware External link to document
2008-10-15 8 to allege infringement of U.S. Patent No. 5,859,021 under the patent laws. Defendants deny ali remaining…and/or enforceable claim of U.S. Patent No. 5,859,021 (“‘021 patent”), either literally or under the …Ofiice issued U.S. Patent No. 5,859,021 (“the ‘021 patent”), entitled “Antiviral Cornbinations,” to nianet…1999, the U.S. Patent and Trademark Office issued U.S. Patent No, 5,905,082 (“the ‘082 patent”), entitied…the °021 patent is attached to the complaint as Exhibit A. Defendants deny that the ‘021 patent was “duly External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
McKinsey
Harvard Business School
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.